Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

J A Kemp Expands in Cambridge

J A Kemp has relocated its Cambridge office today, 14 May, to larger, more modern premises on Capital Park. The firm is more than doubling its office space in Cambridge.

Read the rest of entry »

High Throughput Gene Expression Analysis Service

AMSBIO, a global provider of gene editing and personalized medicine technologies, has launched a service for high throughput gene expression analysis. 

Read the rest of entry »

Aptus Clinical - Ready for Growth

It’s only May and it has already been quite a year for Aptus Clinical. We have added several exceptional individuals to our team, given a well-deserved internal promotion and restructured to ensure efficient project management, seamless client liaison and access to our exceptional talent is at the heart of the client experience.

Read the rest of entry »

Foresight makes £3.5m growth capital investment into Mologic

Investment to support launch of sepsis, COPD and infectious disease diagnostics and international expansion of Contract Research business.

Read the rest of entry »

Chronos Therapeutics Announces Positive Pre-Clinical Proof of Concept Studies for its Orexin-1 Antagonist Project Initially Targeting Binge Eating Disorder

Chronos Therapeutics Ltd (Chronos) the private biotech company focused on ageing diseases, brain and nervous system disorders, announced today that the lead compound in its addiction programme, CT-010018 an orexin-1 antagonist, demonstrated positive pre-clinical proof of concept (POC) results in an in vivo model of binge eating disorder (BED).

Read the rest of entry »

Mologic Signs Agreements with Medisur and Peripal to Distribute PERIPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®

Read the rest of entry »

Crescendo raises $70M to trial bispecific T-cell engager

Crescendo Biologics has raised $70 million (€57 million) to take its lead bispecific T-cell engager into the clinic. The financing equips Crescendo to show whether its vision for dialing up T-cell activity in the tumor microenvironment translates into humans.

Read the rest of entry »

Congratulations to Public Health England (PHE) for winning the British Expertise International Awards 2018

Congratulations to Public Health England (PHE) for winning the British Expertise International Awards 2018 under “international healthcare project” category for “Fast-track global collaborations to conquer emergencies such as Ebola and Zika”.  PHE’s Senior Business Development Manager Professor S.S. Vasan collected the award on his team’s behalf from HRH The Duke of Gloucester KG GCVO on 12 April 2018. Thanking his colleagues “who have made such a difference to our response to Ebola and Zika crises”, Professor Vasan said, “The aspect of our project we are most proud of is collaborations. It is absolutely essential when you are facing a global emergency like Ebola or Zika that we set aside differences, and we keep the focus on saving lives and working in collaboration with industry, academia and non-profit sector so that the response can be very effective and very quick. Every minute saves lives, literally, in this case.”      & ...

Read the rest of entry »

OBN concludes hugely successful BioTrinity 2018 conference

Leading annual life sciences event attracted more than 160 company CEOs, in excess of 150 leading investors and over 80 major pharmaceutical company delegates

Read the rest of entry »

PATH and Mologic advance new malaria test

Seattle, Washington, April 17, 2018—PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria.

Read the rest of entry »

Pages: Previous1234567...15NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.